Biotech Capital Markets Highlights Through June 30th

Week Ending June 30th, 2023

• Biotech: 4 Transactions (3 Follow-Ons and 1 PIPE) totaling just under $800 Million

• Med Tech: No Current Week Financings

2023 YTD

• 89 Biotech transaction totaling just under $12 Billion v. 2022: 65 Biotech transactions totaling just over $7 Billion

• 10 Med Tech transactions totaling just over $600 Millionv. 2022: 3 Med Tech transaction just over $200 Million

Private Transactions:

• Biotech: 118 Transactions / 38 European Transactions

• Med Tech: 71 US Transactions / 27 European Transactions
  

In June, we have seen the following acquisitions:

• Qpex Biopharma acquired by Shionogi ($100M)

• Dice Therapeutics acquired by Eli Lilly ($2.4B)

• Chinook Therapeutics acquired by Novartis ($3.2B)

• Paratek Pharmaceuticals acquired by Gunet Point Capital, Novo Holdings ($123M)

May acquisitions:

• VectivBio acquired by Ironwood Pharmaceuticals ($1.145B)

• CTI Biopharma acquired by Sobi ($1.7B)

Surely there will be a lot more to come!